World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
72
Citations
17422
World Ranking
2234
National Ranking
1080

Overview

Jonathan S. Serody is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily covers areas within medicine, with significant contributions in immunology and microbiology. The scientist's work is further divided into key subfields such as immunology, oncology, hematology, molecular biology, and genetics.

Their research topics focus extensively on:

  • CAR-T cell therapy research
  • Cancer immunotherapy and biomarkers
  • Immunotherapy and immune responses
  • Immune cell function and interaction
  • Hematopoietic stem cell transplantation
  • Lymphoma diagnosis and treatment
  • Immune cells in cancer

Jonathan S. Serody has published numerous articles in various scientific venues. Their frequent publication outlets include:

  • UNC Libraries
  • Blood
  • Cancer Research
  • Journal of Clinical Oncology
  • Blood Advances

Among their recent papers are:

  • Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma, 2020, Journal of Clinical Oncology
  • B Cell Function in the Tumor Microenvironment, 2022, Annual Review of Immunology
  • STING agonist promotes CAR T cell trafficking and persistence in breast cancer, 2020, The Journal of Experimental Medicine
  • Minimal PD-1 expression in mouse and human NK cells under diverse conditions, 2020, Journal of Clinical Investigation
  • Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia, 2021, Blood Cancer Discovery

Frequent collaborators in their research include:

  • Benjamin G. Vincent
  • Gianpietro Dotti
  • Natalie S. Grover
  • Barbara Savoldo
  • Catherine Cheng

Best Publications

  • The Immune Landscape of Cancer.

    Unknown

  • Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy.

    Yuanzeng Min;Kyle C. Roche;Shaomin Tian;Michael J. Eblan

  • Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13.

    Steven L. Highfill;Paulo C. Rodriguez;Qing Zhou;Christine A. Goetz

  • B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer.

    Daniel P. Hollern;Nuo Xu;Aatish Thennavan;Cherise Glodowski

  • L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection

    Patricia A. Taylor;Angela Panoskaltsis-Mortari;Jessica M. Swedin;Philip J. Lucas

  • Leukocyte migration and graft-versus-host disease

    Christian A. Wysocki;Angela Panoskaltsis-Mortari;Bruce R. Blazar;Jonathan S. Serody

  • Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types

    Michael D. Iglesia;Joel S. Parker;Katherine A. Hoadley;Jonathan S. Serody

  • In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations

    Michael J. Carlson;Michelle L. West;James M. Coghill;Angela Panoskaltsis-Mortari

  • Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma.

    Carlos A. Ramos;Carlos A. Ramos;Natalie S. Grover;Anne W. Beaven;Premal D. Lulla;Premal D. Lulla

  • B Cell Function in the Tumor Microenvironment.

    Unknown

  • Alternative tumour-specific antigens.

    Christof C. Smith;Sara R. Selitsky;Shengjie Chai;Paul M. Armistead

  • Intravascular Catheter Exchange and Duration of Candidemia

    John H. Rex;John E. Bennett;Alan M. Sugar;Peter G. Pappas

  • Deconstruction of a Metastatic Tumor Microenvironment Reveals a Common Matrix Response in Human Cancers.

    Oliver Mt Pearce;Robin M Delaine-Smith;Eleni Maniati;Sam Nichols

  • Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

    Kai Sun;Lisbeth A. Welniak;Angela Panoskaltsis-Mortari;Matthew J. O'Shaughnessy

  • Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer

    Michael D. Iglesia;Benjamin G. Vincent;Joel S. Parker;Katherine A. Hoadley

  • Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease

    Christian A. Wysocki;Qi Jiang;Angela Panoskaltsis-Mortari;Patricia A. Taylor

  • Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma

    Christof C. Smith;Kathryn E. Beckermann;Dante S. Bortone;Aguirre A. De Cubas

  • CSF-1–dependant donor-derived macrophages mediate chronic graft-versus-host disease

    Kylie A. Alexander;Ryan Flynn;Katie E. Lineburg;Rachel D. Kuns

  • Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans

    Ryan P Flynn;Jing Du;Rachelle G. Veenstra;Dawn K Reichenbach

  • Ibrutinib treatment ameliorates murine chronic graft-versus-host disease

    Jason A. Dubovsky;Ryan P Flynn;Jing Du;Bonnie K. Harrington

  • Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.

    James M. Coghill;Stefanie Sarantopoulos;Timothy P. Moran;William J. Murphy

  • T-lymphocyte production of macrophage inflammatory protein-1α is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease

    Jonathan S. Serody;Susan E. Burkett;Angela Panoskaltsis-Mortari;Angela Panoskaltsis-Mortari;Angela Panoskaltsis-Mortari;Judith Ng-Cashin

Frequent Co-Authors

Bruce R. Blazar
Bruce R. Blazar University of Minnesota
Angela Panoskaltsis-Mortari
Angela Panoskaltsis-Mortari University of Minnesota
William J. Murphy
William J. Murphy Texas A&M University
Geoffrey R. Hill
Geoffrey R. Hill Fred Hutchinson Cancer Research Center
Patricia A. Taylor
Patricia A. Taylor University of Minnesota
David H. Munn
David H. Munn Augusta University
Leo Luznik
Leo Luznik Johns Hopkins University
Ivan Maillard
Ivan Maillard University of Pennsylvania
Jerome Ritz
Jerome Ritz Harvard University
Kelli P. A. MacDonald
Kelli P. A. MacDonald QIMR Berghofer Medical Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can broaden career opportunities. Nursing programs, especially Licensed Practical Nurse (LPN) paths, provide a solid foundation in patient care. Many students seek accredited lpn programs easy to get into to start their healthcare journey without extensive prerequisites.

Advancing further, Nurse Practitioner (NP) degrees are a popular choice for those aiming to specialize. Prospective students often look for easiest np programs to get into that balance quality education and accessibility, enabling a smooth transition into advanced practice roles.

For those with an interest in mental health linked to immunological research, online Psychiatric Mental Health Nurse Practitioner (PMHNP) programs are highly relevant. Finding programs with the best online pmhnp programs ensures access to quality clinical placements, a crucial part of practical training.

Cost is also a significant factor. Students often prioritize cheapest pmhnp programs online to manage education expenses while gaining necessary qualifications. These options make advanced healthcare education more attainable for many aspiring professionals.

Best Scientists Citing Jonathan S. Serody

Trending Scientists

Recently Published Articles